SCHEMBL29298622

SCHEMBL29298622

c1ccc(-c2cc(-c3nc(-c4ccc5ccccc5c4)nc(-c4cccc5ccccc45)n3)cc3c2oc2cc4ccccc4cc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.39
▸ MAPT P10636 3/20 0.39
▸ KDM4E B2RXH2 4/20 0.36
▸ HSD17B10 Q99714 4/20 0.36
▸ TP53 P04637 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ ATM Q13315 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ PIM1 P11309 2/20 0.35
▸ CYP1A2 P05177 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ PRKDC P78527 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29298628 0.93 ALDH1A1 (0.42) ALDH1A1MAPTKDM4EHSD17B10TP53
SCHEMBL24586854 0.93 ALOX5 (0.41) ALDH1A1MAPTKDM4EHSD17B10TP53
SCHEMBL24586852 0.92 ALDH1A1 (0.40) ALDH1A1MAPTKDM4EHSD17B10TP53
SCHEMBL29298625 0.91 CYP1B1 (0.38) ALDH1A1MAPTKDM4EHSD17B10TP53
SCHEMBL24066098 0.91 ALDH1A1 (0.42) ALDH1A1MAPTKDM4EHSD17B10TP53
SCHEMBL27101467 0.91 ALDH1A1 (0.42) ALDH1A1MAPTKDM4EHSD17B10TP53
SCHEMBL29298619 0.91 ALDH1A1 (0.42) ALDH1A1MAPTKDM4EHSD17B10TP53
SCHEMBL29298621 0.90 KDM4E (0.36) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL24586855 0.90 KDM4E (0.38) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL29298620 0.90 ALDH1A1 (0.41) ALDH1A1MAPTKDM4EHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2024-07-11 — — US disclosed
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER CYP1A1, CYP1B1, CYP2E1 ALDH1A1 16/4885MAPT 1117/4885KDM4E 3419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback